Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessCompanies

Glenmark enters pact with Novartis to distribute respiratory drugs in Brazil

Under the terms of the agreement, Novartis remains the holder of the registration of these medicines and will be responsible to manufacture them, Glenmark will be responsible for promoting, commercializing and distributing of these products in Brazil.

June 24, 2019 / 01:14 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drugmaker Glenmark Pharmaceuticals on June 24 said its Brazilian subsidiary, Glenmark Farmacêutica, has entered into an exclusive partnership agreement with Novartis to distribute latter's three respiratory products in Brazil.

This agreement will be effective from July 1 onwards.

The products involved in the agreement are Seebri (Glycopyrronium bromide), Onbrize (Indacaterol) and Ultibro (combination of Indacaterol and Glycopyrronium), which are indicated towards treatment of the symptoms of chronic obstructive pulmonary disease (COPD) in adults.

Under the terms of the agreement, Novartis remains the holder of the registration of these medicines and will be responsible to manufacture them. Glenmark will be responsible for promoting, commercializing and distributing of these products in Brazil.

“This partnership is in line with our vision to expand our respiratory product offerings for patients and prescribers in Brazil and further consolidate our position in this segment,” said Glenn Saldanha, Chairman and Managing Director of Glenmark.

Latin America, that constitutes Brazil contributed about 5 percent of Glenmark's Rs 9865.5. Indian drug makers who are facing intense pricing pressure in their key US market have been focusing on ramping up their sales in other big geographies such as Brazil.

Shares of Glenmark were trading 7.3 percent lower and were trading at Rs 463 on BSE at 1 pm.

Moneycontrol News
first published: Jun 24, 2019 01:14 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347